The best medicine for a sinus infection depends on the cause: for a confirmed bacterial sinus infection, amoxicillin or amoxicillin-clavulanate (Augmentin) is first-line, at 500–875 mg twice daily for 5–10 days. But most acute sinus infections — roughly 90–98 percent — are viral and need no antibiotic at all. For symptom relief, the strongest evidence supports intranasal corticosteroid sprays plus saline irrigation; oral decongestants and antihistamines offer little benefit and can worsen congestion. The single most important decision is whether bacteria are actually involved.
What Actually Causes Sinus Inflammation
Acute rhinosinusitis starts when the sinus ostia — the drainage openings, typically 1–3 mm wide — become blocked by swollen mucosa. Mucus then stagnates, oxygen tension inside the sinus drops, and the local immune response shifts. That environment is what allows bacteria to proliferate; the infection is a downstream consequence of obstruction, not its cause.
This mechanism explains why decongestants feel helpful but disappoint over time. They shrink the nasal mucosa for a few hours and open the drainage pathways. Rebound congestion after 3 or more consecutive days of oxymetazoline use can re-close those same pathways. In plain terms: unblocking the drain matters more than killing bacteria in most cases.
Viral pathogens cause the large majority of cases — rhinovirus, influenza, parainfluenza, and adenovirus are the usual suspects. Only about 0.5–2 percent of viral upper respiratory infections progress to a secondary bacterial sinusitis, per the 2015 IDSA clinical practice guideline. A bacterial diagnosis is a minority event.
Viral vs. Bacterial: The Numbers That Decide Treatment
Distinguishing the two determines everything about the medicine choice. The classic signals of bacterial infection include symptoms lasting 10 days or more without improvement, a "double worsening" (improvement then relapse around day 5–6), or high fever with purulent discharge for 3–4 consecutive days at onset.
Timing is the most reliable single axis. A viral infection peaks around day 2–3 and improves steadily. Bacterial infection either drags past 10 days or crashes back after initial improvement. Antibiotics given before day 10 in a stable patient rarely change outcomes and add roughly 5–25 percent risk of adverse effects, mostly diarrhea and rash.
| Scenario | Typical duration | Likely cause | Antibiotic indicated? |
|---|---|---|---|
| Improving after 5–7 days | Under 10 days | Viral | No |
| Double worsening at day 5–6 | 7–10 days | Viral or early bacterial | Usually no; reassess |
| Symptoms over 10 days, no improvement | 10+ days | Bacterial | Yes, first-line |
| Fever over 101°F (38.3°C) plus purulence for 3–4 days at onset | 4+ days | Bacterial | Often yes |
| Severe facial pain, fever over 102°F (39°C) | 3–4 days | Bacterial | Yes, urgent evaluation |
Note the threshold reconciliation: the "10-day" rule applies to persisting, non-improving symptoms, while the "3–4 day" high-fever rule applies only at onset and only with purulent discharge. These are alternative triggers, not additive ones — either can justify antibiotics, but neither should be applied to a stable patient who is already improving.
First-Line Antibiotics and Dosing
For adults with confirmed bacterial acute rhinosinusitis, the 2015 IDSA guideline recommends amoxicillin-clavulanate at 500 mg/125 mg three times daily or 875 mg/125 mg twice daily for 5 to 10 days. Amoxicillin alone at 500 mg three times daily is an acceptable alternative in patients without recent antibiotic exposure or risk factors for resistance.
Course length has shifted downward. A 2018meta-analysis of 12 randomized trials found 5–7 day courses performed comparably to 10–14 day courses in adults, with fewer side effects. Many clinicians now default to 5–7 days in uncomplicated cases.
For penicillin allergy, alternatives include doxycycline at 100 mg twice daily or a respiratory fluoroquinolone such as levofloxacin at 500 mg daily — though the FDA has warned that fluoroquinolones carry risks of tendon rupture and aortic events that make them a second-line choice. Macrolides like azithromycin are no longer recommended as monotherapy because pneumococcal resistance exceeds 30 percent in many U.S. regions.
Pediatric dosing differs by weight and is typically 45–90 mg/kg per day of amoxicillin-clavulanate divided twice daily. Children with bacterial sinusitis also warrant a lower threshold for imaging if symptoms are severe.
Over-the-Counter Medicines: What the Evidence Supports
OTC options split into two tiers. Adjuncts with measurable benefit include intranasal corticosteroids — budesonide or fluticasone — which reduce mucosal swelling and improve symptom scores in trials, particularly when added to antibiotics. Saline irrigation (isotonic or hypertonic) mechanically clears mucus and improves symptom scores modestly; a 2019 study found hypertonic saline outperformed isotonic for symptom relief.
Adjuncts with minimal or no proven benefit include oral decongestants (pseudoephedrine), antihistamines (which dry secretions and can thicken mucus), and guaifenesin. Decongestant spray (oxymetazoline) works but only for 3 consecutive days before rebound. A 2012 Cochrane review found no meaningful benefit of oral decongestants or antihistamines added to antibiotics for acute sinusitis.
| Medicine | Class | Evidence strength | Typical adult dose | Key caveat |
|---|---|---|---|---|
| Amoxicillin-clavulanate | Antibiotic | High (bacterial) | 875/125 mg twice daily | Only if bacterial criteria met |
| Intranasal fluticasone | Corticosteroid | Moderate-high (adjunct) | 1–2 sprays per nostril daily | Best with irrigation |
| Hypertonic saline irrigation | Mechanical | Moderate | 1–2 rinses daily | Use distilled or boiled water |
| Pseudoephedrine | Oral decongestant | Low | 30–60 mg every 4–6 hours | Avoid if hypertensive |
| Oxymetazoline spray | Topical decongestant | High short-term | 2 sprays per nostril twice daily | Rebound after 3 days |
| Azithromycin | Antibiotic | Low (resistance) | 500 mg day 1, then 250 mg | Not first-line |
How Long It Takes: Symptom Timeline
Symptom resolution is the outlier among respiratory infections — slower than most patients expect. Even with optimal treatment, bacterial sinusitis symptoms typically take 7–14 days to meaningfully improve, and residual congestion can persist 2–4 weeks.
| Time point | What to expect |
|---|---|
| Day 0–1 | Onset; congestion, facial pressure, possible fever |
| Day 2–5 | Peak viral symptoms; purulent discharge common even in viral cases |
| Day 5–7 | Improves in viral; double-worsening suggests bacterial |
| Day 10 | If no improvement, bacterial cause likely |
| Day 10–14 | With antibiotics, first clear improvement usually appears |
| Day 14–21 | Most bacterial cases resolve; cough may linger |
| Day 21–28 | Mild residual congestion acceptable; reassess if worse |
| Week 4+ | Persistent symptoms warrant imaging (CT) and ENT referral |
In plain terms: judge antibiotics by day 3–4 of therapy, not day 1. A lack of any improvement after 72 hours of appropriate antibiotics suggests the diagnosis is wrong, the drug is wrong, or there is a complication.
Red Flags That Override Any Home Treatment
Seek urgent care immediately for any of the following. These are bulleted because each is an emergency signal, not a nuance:
- Swelling or redness around the eye, vision changes, or eye pain on movement (orbital cellulitis)
- Severe headache with neck stiffness, confusion, or high fever (meningitis or intracranial spread)
- Facial swelling, numbness, or skin redness over the cheek or forehead
- Symptoms that worsen sharply after initial improvement despite antibiotics
- Inability to control a fever above 103°F (39.4°C) with medication
- Any sinus symptoms in an immunocompromised patient
These reflect extension of infection beyond the sinus cavity and occur in under 1 percent of cases but carry substantial risk if missed.
Common Misconceptions and What to Actually Do
The most persistent misconception is that yellow or green mucus means bacterial infection. Color comes from neutrophils and myeloperoxidase, not bacteria specifically, and appears in most viral infections by day 3–4. A second misconception is that antibiotics "prevent" sinus infections from worsening; they do not help viral cases and may increase subsequent resistance risk.
A third, less obvious point: antihistamines and decongestants can actually prolong symptoms. Drying secretions thickens them, slowing clearance. In plain terms: thin the mucus, don't dry it.
Practical actions, in order of impact: Start hypertonic saline irrigation twice daily at first symptoms. Add intranasal fluticasone if symptoms persist beyond 5 days. Use oxymetazoline for no more than 3 days. Only pursue antibiotics if you meet the 10-day or severe-onset criteria. Get a CT scan and ENT referral if symptoms exceed 4 weeks or red flags appear. Expect gradual, not rapid, improvement — day 3–4 is the first fair checkpoint on antibiotics.
The limits are real: this framework is strongest for adults with uncomplicated disease. Chronic rhinosinusitis (over 12 weeks) follows different rules, often involving polyps, allergy, or fungal components, and topical steroids plus allergy control outperform antibiotics. Recurrent acute cases (4 or more per year) warrant evaluation for anatomic obstruction. And no medicine substitutes for accurate diagnosis — which remains the highest-value step in the entire pathway.